Inventor
KUMAR RAVINDRA
US163 patents
⚠️ This page may combine multiple inventors who share the name “KUMAR RAVINDRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACCELERON PHARMA INC
31 patentsUS8343933B2Jan 1, 2013
Variants derived from ActRIIB and uses therefor
ACCELERON PHARMA INC91 citations99
US7842663B2Nov 30, 2010
Variants derived from ActRIIB and uses therefor
ACCELERON PHARMA INC135 citations99
US8361957B2Jan 29, 2013
Isolated GDF trap polypeptide
ACCELERON PHARMA INC42 citations98
US10722558B2Jul 28, 2020
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC15 citations94
US10695405B2Jun 30, 2020
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC13 citations94
US10377996B2Aug 13, 2019
Methods of identifying ActRIIB variants
ACCELERON PHARMA INC24 citations94
US10358633B2Jul 23, 2019
Method for producing an ActRIIB-Fc fusion polypeptide
ACCELERON PHARMA INC15 citations94
US10259861B2Apr 16, 2019
Variants derived from ActRIIB and uses therefor
ACCELERON PHARMA INC22 citations94
US10131700B2Nov 20, 2018
Methods for treating refractory anemia with ringed sideroblasts
ACCELERON PHARMA INC20 citations94
US9932379B2Apr 3, 2018
Isolated nucleotide sequences encoding GDF traps
ACCELERON PHARMA INC19 citations94
US9745559B2Aug 29, 2017
Method for decreasing the body fat content in a subject by administering an ActRIIB protein
ACCELERON PHARMA INC22 citations94
US9399669B2Jul 26, 2016
Variants derived from ActRIIB
ACCELERON PHARMA INC27 citations94
US9181533B2Nov 10, 2015
Truncated ACTRIIB-FC fusion protein
ACCELERON PHARMA INC26 citations93
US9809637B2Nov 7, 2017
Transforming growth factor beta receptor II fusion polypeptides
ACCELERON PHARMA INC19 citations92
US9505813B2Nov 29, 2016
Use of GDF traps to treat anemia
ACCELERON PHARMA INC20 citations92
US9439945B2Sep 13, 2016
Isolated nucleotide sequences encoding GDF traps
ACCELERON PHARMA INC18 citations92
US11622992B2Apr 11, 2023
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC3 citations84
US11219666B2Jan 11, 2022
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC5 citations84
US11065303B2Jul 20, 2021
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC6 citations84
US11028145B2Jun 8, 2021
ALK7:actriib heteromultimers and uses thereof
ACCELERON PHARMA INC4 citations84
US10973880B2Apr 13, 2021
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC7 citations84
US10946067B2Mar 16, 2021
Compositions and methods for treating pulmonary hypertension
ACCELERON PHARMA INC6 citations84
US10889626B2Jan 12, 2021
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC4 citations84
US10829532B2Nov 10, 2020
Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC4 citations84
US10738098B2Aug 11, 2020
ALK4:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC6 citations84
US10689427B2Jun 23, 2020
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC7 citations84
US10358476B2Jul 23, 2019
Single arm type I and type II receptor fusion proteins and uses thereof
ACCELERON PHARMA INC12 citations84
US10307455B2Jun 4, 2019
Activin type 2 receptor antibodies
ACCELERON PHARMA INC5 citations84
US10227393B2Mar 12, 2019
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
ACCELERON PHARMA INC9 citations84
US10023621B2Jul 17, 2018
Follistatin-related fusion proteins
ACCELERON PHARMA INC5 citations84
US9790284B2Oct 17, 2017
Methods for increasing thermogenic adipocytes
ACCELERON PHARMA INC5 citations84
SEEHRA JASBIR
6 patentsUS8216997B2Jul 10, 2012
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
SEEHRA JASBIR100 citations99
US8058229B2Nov 15, 2011
Method of increasing red blood cell levels or treating anemia in a patient
SEEHRA JASBIR97 citations99
US8703927B2Apr 22, 2014
Isolated nucleotide sequences encoding GDF traps
SEEHRA JASBIR57 citations98
US8293881B2Oct 23, 2012
Isolated nucleic acid encoding a truncated ActRIIB fusion protein
SEEHRA JASBIR73 citations98
US8138142B2Mar 20, 2012
Methods for increasing adiponectin in a patient in need thereof
SEEHRA JASBIR82 citations96
US8765663B2Jul 1, 2014
Methods for increasing adiponectin
SEEHRA JASBIR38 citations93
KNOPF JOHN
5 patentsUS8178488B2May 15, 2012
Methods for increasing thermogenic adipocytes
KNOPF JOHN92 citations99
US8703694B2Apr 22, 2014
Methods for increasing thermogenic adipocytes
KNOPF JOHN43 citations98
US9526759B2Dec 27, 2016
Activin-actriia antagonists and uses for treating or preventing breast cancer
KNOPF JOHN38 citations94
US8173601B2May 8, 2012
Activin-ActRIIa antagonists and uses for treating multiple myeloma
KNOPF JOHN42 citations94
US9572865B2Feb 21, 2017
Activin-actriia antagonists and uses for treating multiple myeloma
KNOPF JOHN16 citations93
GENETICS INST
5 patentsUS5827817AOct 27, 1998
P-selectin ligand protein
GENETICS INST146 citations98
US5840679ANov 24, 1998
Method of inhibiting P-selectin ligand activity
GENETICS INST98 citations97
US6277975B1Aug 21, 2001
Fusions of P-selectin ligand protein and polynucleotides encoding same
GENETICS INST34 citations95
US5843707ADec 1, 1998
Nucleic acid encoding a novel P-selectin ligand protein
GENETICS INST71 citations95
US5728568AMar 17, 1998
Human GDP-mannose 4,6 dehydratase
GENETICS INST84 citations95
NETAPP INC
2 patentsGENETICS INST LLC
1 patentShowing the top 50 of 163 patents by PatentIndex Score.